Gossamer Bio Inc (NASDAQ: GOSS) is 4.33% higher on its value in year-to-date trading and has touched a low of $0.45 and a high of $1.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GOSS stock was last observed hovering at around $0.98 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.95, the stock is 3.11% and 2.83% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.8 million and changing -3.15% at the moment leaves the stock 1.78% off its SMA200. GOSS registered 21.21% gain for a year compared to 6-month loss of -18.63%. The firm has a 50-day simple moving average (SMA 50) of $0.9231 and a 200-day simple moving average (SMA200) of $0.934985.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 4.18% gain in the last 1 month and extending the period to 3 months gives it a -0.01%, and is -0.81% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.38% over the week and 8.62% over the month.
Gossamer Bio Inc (GOSS) has around 135 employees, a market worth around $215.37M and $95.84M in sales. Profit margin for the company is -84.36%. Distance from 52-week low is 110.39% and -40.50% from its 52-week high. The company has generated returns on investments over the last 12 months (-29.02%).
The EPS is expected to grow by 77.55% this year
104.0 institutions hold shares in Gossamer Bio Inc (GOSS), with institutional investors hold 83.60% of the company’s shares. The shares outstanding are 225.41M, and float is at 186.86M with Short Float at 4.58%. Institutions hold 81.13% of the Float.
The top institutional shareholder in the company is NEA MANAGEMENT COMPANY, LLC with over 18.09 million shares valued at $16.3 million. The investor’s holdings represent 8.0152 of the GOSS Shares outstanding. As of 2024-06-30, the second largest holder is ARTAL GROUP S.A. with 13.31 million shares valued at $11.99 million to account for 5.8958 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.76 million shares representing 5.2098 and valued at over $10.59 million, while OCTAGON CAPITAL ADVISORS LP holds 4.0702 of the shares totaling 9.19 million with a market value of $8.28 million.
Gossamer Bio Inc (GOSS) Insider Activity
The most recent transaction is an insider sale by Aranda Richard, the company’s Chief Medical Officer. SEC filings show that Aranda Richard sold 1,908 shares of the company’s common stock on Jun 24 ’24 at a price of $0.66 per share for a total of $1260.0. Following the sale, the insider now owns 0.2 million shares.
Gossamer Bio Inc disclosed in a document filed with the SEC on Jun 21 ’24 that Hasnain Faheem (President & CEO) bought a total of 372,000 shares of the company’s common stock. The trade occurred on Jun 21 ’24 and was made at $0.67 per share for $0.25 million. Following the transaction, the insider now directly holds 5.41 million shares of the GOSS stock.
Still, SEC filings show that on Jun 18 ’24, Giraudo Bryan (COO/CFO) acquired 100,000 shares at an average price of $0.59 for $59110.0. The insider now directly holds 480,010 shares of Gossamer Bio Inc (GOSS).
